NEXGEL, Inc.
$0.64
▼
-5.38%
2026-04-21 08:33:00
nexgel.com
NCM: NXGL
Explore NEXGEL, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$6.98 M
Current Price
$0.64
52W High / Low
$2.99 / $0.56
Stock P/E
—
Book Value
$0.64
Dividend Yield
—
ROCE
-41.75%
ROE
-52.74%
Face Value
—
EPS
$-0.38
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
19
Beta
0.85
Debt / Equity
63.14
Current Ratio
1.47
Quick Ratio
0.75
Forward P/E
2.49
Price / Sales
0.42
Enterprise Value
$8.05 M
EV / EBITDA
-2.77
EV / Revenue
0.7
Rating
None
Target Price
$2
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Avantor, Inc. | $8.5 | — | $5.76 B | — | 5.22% | -9.2% | $16.17 / $7.26 | $8.24 |
| 2. | Solventum Corporation | $69.51 | 7.83 | $12.08 B | — | 5.66% | 38.86% | $88.2 / $62.38 | $29.1 |
| 3. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
| 4. | Femasys Inc. | $0.42 | — | $25.6 M | — | -460.52% | -4.56% | $1.29 / $0.31 | $0.1 |
| 5. | Becton, Dickinson and Company | $155.63 | 25.5 | $44.7 B | 2.65% | 6.35% | 6.96% | $187.35 / $127.54 | $88.79 |
| 6. | KORU Medical Systems, Inc. | $4.26 | — | $200.78 M | — | -14.86% | -15.58% | $6.61 / $2.08 | $0.37 |
| 7. | Sanara MedTech Inc. | $20.62 | — | $190.4 M | — | 16.84% | -1.75% | $35.95 / $16.05 | $0.66 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.8 M | 2.93 M | 2.88 M | 2.81 M | 3.04 M | — |
| Operating Profit | -1.21 M | -0.72 M | -0.64 M | -0.78 M | -0.84 M | — |
| Net Profit | -0.97 M | -0.65 M | -0.67 M | -0.71 M | -0.85 M | — |
| EPS in Rs | -0.11 | -0.08 | -0.08 | -0.08 | -0.1 | -0.11 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 11.42 M | 8.69 M | 4.09 M | 2.05 M |
| Operating Profit | -3.35 M | -3.55 M | -3.48 M | -3.35 M |
| Net Profit | -3 M | -3.28 M | -3.16 M | -4.75 M |
| EPS in Rs | -0.35 | -0.39 | -0.37 | -0.56 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.46 M | 10.98 M | 9.96 M | 10.36 M |
| Total Liabilities | 5.57 M | 4.9 M | 4.79 M | 2.72 M |
| Equity | 4.46 M | 5.75 M | 4.7 M | 7.64 M |
| Current Assets | 4.34 M | 5.11 M | 5.05 M | 7.5 M |
| Current Liabilities | 2.96 M | 2.47 M | 2.55 M | 0.86 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -1.31 M | -3.87 M | -3.24 M | -2.99 M |
| Investing CF | -0.07 M | -0.78 M | 4.46 M | -5.59 M |
| Financing CF | 0.63 M | 3.75 M | 0.38 M | -3.66 M |
| Free CF | -1.38 M | -4.31 M | -3.93 M | -3.09 M |
| Capex | -0.07 M | -0.44 M | -0.7 M | -0.1 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 112.47% | 99.66% | — | — |
| Earnings Growth % | -3.93% | 33.48% | — | — |
| Profit Margin % | -37.76% | -77.21% | -231.74% | — |
| Operating Margin % | -40.91% | -85.03% | -163.48% | — |
| Gross Margin % | 31.63% | 9.15% | 12.5% | — |
| EBITDA Margin % | -31.27% | -66.76% | -151.81% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.